Lord Mancroft – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Lord Mancroft on 2016-04-14.
To ask Her Majesty’s Government what impact assessment they made of the introduction of CQUIN scheme BI1 Improving HCV Treatment Pathways through ODNs, and whether they will publish a copy of that assessment.
Lord Prior of Brampton
The National Institute for Health and Care Excellence specifically requires Operational Delivery Networks to prioritise hepatitis C patients on the basis of clinical need, as part of a progressive rollout of treatments over the next five years and the Commissioning for Quality and Innovation scheme (CQUIN) enables and ensures this take place. There is no separate assessment of impact. NHS England recognises that there is a very significant improvement in inequalities as a result of roll-out treatment for hepatitis C.
